|
|
MDS Incorporated - Comparative Business Analysis Snapshot
Business Description
MDS Incorporated. The Group's principal activity is to provide products and services for the development of drugs and diagnosis and treatment of diseases. It operates through three segments. The Pharmaceutical Research Services segment provides research services on contract from pre-clinical development to Phase II(a) clinical trials. The Isotopes and Molecular Imaging segment produces Isotopes used in the diagnosis and treatment of diseases and to sterilize medical and other products, including food. In addition, it also manufactures and sells isotope-based cancer therapy equipment. The Analytical Instruments segment designs, develops and manufactures analytical instruments and related operating systems, software and other products. On 20-Mar-2007, the Group acquired Molecular Devices Corporation.
Competitor Analysis
This analysis compares MDS Incorporated with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
